Global Hereditary Angioedema Treatment Market Research Report 2025(Status and Outlook)
Report Overview
Hereditary Angioedema (HAE) treatment refers to the medical interventions aimed at managing and alleviating the symptoms of this rare genetic disorder characterized by recurrent episodes of swelling in various body parts. The treatment options for HAE typically involve acute therapies to address sudden attacks and prophylactic therapies to prevent future episodes. Acute treatments may include medications like C1 esterase inhibitors, bradykinin receptor antagonists, or plasma kallikrein inhibitors, while prophylactic therapies often involve long-term use of attenuated androgens or C1 esterase inhibitors to reduce the frequency and severity of attacks. Additionally, supportive care such as pain management and monitoring for potential complications are essential components of HAE treatment.
The market for Hereditary Angioedema treatment is witnessing significant growth driven by several key factors. Firstly, increasing awareness about rare diseases and advancements in diagnostic techniques have led to improved detection rates of HAE cases, thereby expanding the patient pool in need of treatment. Secondly, the growing focus on research and development in the pharmaceutical industry has resulted in the introduction of novel therapies with enhanced efficacy and safety profiles, offering patients more options for managing their condition. Moreover, collaborations between healthcare providers, patient advocacy groups, and pharmaceutical companies have facilitated access to HAE treatments, ensuring better outcomes for patients. These market drivers are expected to continue fueling the growth of the Hereditary Angioedema treatment market in the coming years.
In addition to the aforementioned market drivers, the market trend for Hereditary Angioedema treatment also includes factors such as increasing healthcare expenditure, particularly in developed regions, which supports the adoption of advanced therapies for rare diseases like HAE. Furthermore, the emphasis on personalized medicine and precision healthcare is driving the development of targeted treatments tailored to individual patient needs, leading to more effective management of HAE symptoms. The market is also witnessing a rise in strategic partnerships and collaborations between pharmaceutical companies and research institutions to accelerate drug development and improve treatment outcomes for HAE patients. Overall, the market for Hereditary Angioedema treatment is poised for continued growth and innovation, driven by evolving patient needs and advancements in medical science.
This report provides a deep insight into the global Hereditary Angioedema Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hereditary Angioedema Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hereditary Angioedema Treatment market in any manner.
Global Hereditary Angioedema Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CSL
Pharming Group
Shire plc (Takeda Pharmaceutical Company Limited)
Ionis Pharmaceuticals
Attune Pharmaceuticals
BioCryst Pharmaceuticals
KalVista Pharmaceuticals
Market Segmentation (by Type)
C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Kallikrein Inhibitors (Kalbitor, Takhzyro)
Others (Conventional Drugs, Pipeline Drugs)
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Others (online pharmacies, mail pharmacies)
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hereditary Angioedema Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Hereditary Angioedema (HAE) treatment refers to the medical interventions aimed at managing and alleviating the symptoms of this rare genetic disorder characterized by recurrent episodes of swelling in various body parts. The treatment options for HAE typically involve acute therapies to address sudden attacks and prophylactic therapies to prevent future episodes. Acute treatments may include medications like C1 esterase inhibitors, bradykinin receptor antagonists, or plasma kallikrein inhibitors, while prophylactic therapies often involve long-term use of attenuated androgens or C1 esterase inhibitors to reduce the frequency and severity of attacks. Additionally, supportive care such as pain management and monitoring for potential complications are essential components of HAE treatment.
The market for Hereditary Angioedema treatment is witnessing significant growth driven by several key factors. Firstly, increasing awareness about rare diseases and advancements in diagnostic techniques have led to improved detection rates of HAE cases, thereby expanding the patient pool in need of treatment. Secondly, the growing focus on research and development in the pharmaceutical industry has resulted in the introduction of novel therapies with enhanced efficacy and safety profiles, offering patients more options for managing their condition. Moreover, collaborations between healthcare providers, patient advocacy groups, and pharmaceutical companies have facilitated access to HAE treatments, ensuring better outcomes for patients. These market drivers are expected to continue fueling the growth of the Hereditary Angioedema treatment market in the coming years.
In addition to the aforementioned market drivers, the market trend for Hereditary Angioedema treatment also includes factors such as increasing healthcare expenditure, particularly in developed regions, which supports the adoption of advanced therapies for rare diseases like HAE. Furthermore, the emphasis on personalized medicine and precision healthcare is driving the development of targeted treatments tailored to individual patient needs, leading to more effective management of HAE symptoms. The market is also witnessing a rise in strategic partnerships and collaborations between pharmaceutical companies and research institutions to accelerate drug development and improve treatment outcomes for HAE patients. Overall, the market for Hereditary Angioedema treatment is poised for continued growth and innovation, driven by evolving patient needs and advancements in medical science.
This report provides a deep insight into the global Hereditary Angioedema Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hereditary Angioedema Treatment Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hereditary Angioedema Treatment market in any manner.
Global Hereditary Angioedema Treatment Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
CSL
Pharming Group
Shire plc (Takeda Pharmaceutical Company Limited)
Ionis Pharmaceuticals
Attune Pharmaceuticals
BioCryst Pharmaceuticals
KalVista Pharmaceuticals
Market Segmentation (by Type)
C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Kallikrein Inhibitors (Kalbitor, Takhzyro)
Others (Conventional Drugs, Pipeline Drugs)
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Others (online pharmacies, mail pharmacies)
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Hereditary Angioedema Treatment Market
- Overview of the regional outlook of the Hereditary Angioedema Treatment Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hereditary Angioedema Treatment Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Hereditary Angioedema Treatment
1.2 Key Market Segments
1.2.1 Hereditary Angioedema Treatment Segment by Type
1.2.2 Hereditary Angioedema Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HEREDITARY ANGIOEDEMA TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hereditary Angioedema Treatment Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Hereditary Angioedema Treatment Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HEREDITARY ANGIOEDEMA TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Hereditary Angioedema Treatment Product Life Cycle
3.3 Global Hereditary Angioedema Treatment Sales by Manufacturers (2020-2025)
3.4 Global Hereditary Angioedema Treatment Revenue Market Share by Manufacturers (2020-2025)
3.5 Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Hereditary Angioedema Treatment Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Hereditary Angioedema Treatment Sales Sites, Area Served, Product Type
3.8 Hereditary Angioedema Treatment Market Competitive Situation and Trends
3.8.1 Hereditary Angioedema Treatment Market Concentration Rate
3.8.2 Global 5 and 10 Largest Hereditary Angioedema Treatment Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HEREDITARY ANGIOEDEMA TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Hereditary Angioedema Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HEREDITARY ANGIOEDEMA TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 PEST Analysis
5.6.1 Industry Policies Analysis
5.6.2 Economic Environment Analysis
5.6.3 Social Environment Analysis
5.6.4 Technological Environment Analysis
5.7 Global Hereditary Angioedema Treatment Market Porter's Five Forces Analysis
5.7.1 Global Trade Frictions
5.7.2 Global Trade Frictions and Their Impacts to Hereditary Angioedema Treatment Market
5.8 ESG Ratings of Leading Companies
6 HEREDITARY ANGIOEDEMA TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hereditary Angioedema Treatment Sales Market Share by Type (2020-2025)
6.3 Global Hereditary Angioedema Treatment Market Size Market Share by Type (2020-2025)
6.4 Global Hereditary Angioedema Treatment Price by Type (2020-2025)
7 HEREDITARY ANGIOEDEMA TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hereditary Angioedema Treatment Market Sales by Application (2020-2025)
7.3 Global Hereditary Angioedema Treatment Market Size (M USD) by Application (2020-2025)
7.4 Global Hereditary Angioedema Treatment Sales Growth Rate by Application (2020-2025)
8 HEREDITARY ANGIOEDEMA TREATMENT MARKET SALES BY REGION
8.1 Global Hereditary Angioedema Treatment Sales by Region
8.1.1 Global Hereditary Angioedema Treatment Sales by Region
8.1.2 Global Hereditary Angioedema Treatment Sales Market Share by Region
8.2 Global Hereditary Angioedema Treatment Market Size by Region
8.2.1 Global Hereditary Angioedema Treatment Market Size by Region
8.2.2 Global Hereditary Angioedema Treatment Market Size Market Share by Region
8.3 North America
8.3.1 North America Hereditary Angioedema Treatment Sales by Country
8.3.2 North America Hereditary Angioedema Treatment Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Hereditary Angioedema Treatment Sales by Country
8.4.2 Europe Hereditary Angioedema Treatment Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Hereditary Angioedema Treatment Sales by Region
8.5.2 Asia Pacific Hereditary Angioedema Treatment Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Hereditary Angioedema Treatment Sales by Country
8.6.2 South America Hereditary Angioedema Treatment Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Hereditary Angioedema Treatment Sales by Region
8.7.2 Middle East and Africa Hereditary Angioedema Treatment Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HEREDITARY ANGIOEDEMA TREATMENT MARKET PRODUCTION BY REGION
9.1 Global Production of Hereditary Angioedema Treatment by Region(2020-2025)
9.2 Global Hereditary Angioedema Treatment Revenue Market Share by Region (2020-2025)
9.3 Global Hereditary Angioedema Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Hereditary Angioedema Treatment Production
9.4.1 North America Hereditary Angioedema Treatment Production Growth Rate (2020-2025)
9.4.2 North America Hereditary Angioedema Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Hereditary Angioedema Treatment Production
9.5.1 Europe Hereditary Angioedema Treatment Production Growth Rate (2020-2025)
9.5.2 Europe Hereditary Angioedema Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Hereditary Angioedema Treatment Production (2020-2025)
9.6.1 Japan Hereditary Angioedema Treatment Production Growth Rate (2020-2025)
9.6.2 Japan Hereditary Angioedema Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Hereditary Angioedema Treatment Production (2020-2025)
9.7.1 China Hereditary Angioedema Treatment Production Growth Rate (2020-2025)
9.7.2 China Hereditary Angioedema Treatment Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CSL
10.1.1 CSL Basic Information
10.1.2 CSL Hereditary Angioedema Treatment Product Overview
10.1.3 CSL Hereditary Angioedema Treatment Product Market Performance
10.1.4 CSL Business Overview
10.1.5 CSL SWOT Analysis
10.1.6 CSL Recent Developments
10.2 Pharming Group
10.2.1 Pharming Group Basic Information
10.2.2 Pharming Group Hereditary Angioedema Treatment Product Overview
10.2.3 Pharming Group Hereditary Angioedema Treatment Product Market Performance
10.2.4 Pharming Group Business Overview
10.2.5 Pharming Group SWOT Analysis
10.2.6 Pharming Group Recent Developments
10.3 Shire plc (Takeda Pharmaceutical Company Limited)
10.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Basic Information
10.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Overview
10.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Market Performance
10.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Business Overview
10.3.5 Shire plc (Takeda Pharmaceutical Company Limited) SWOT Analysis
10.3.6 Shire plc (Takeda Pharmaceutical Company Limited) Recent Developments
10.4 Ionis Pharmaceuticals
10.4.1 Ionis Pharmaceuticals Basic Information
10.4.2 Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Overview
10.4.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Market Performance
10.4.4 Ionis Pharmaceuticals Business Overview
10.4.5 Ionis Pharmaceuticals Recent Developments
10.5 Attune Pharmaceuticals
10.5.1 Attune Pharmaceuticals Basic Information
10.5.2 Attune Pharmaceuticals Hereditary Angioedema Treatment Product Overview
10.5.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Product Market Performance
10.5.4 Attune Pharmaceuticals Business Overview
10.5.5 Attune Pharmaceuticals Recent Developments
10.6 BioCryst Pharmaceuticals
10.6.1 BioCryst Pharmaceuticals Basic Information
10.6.2 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Overview
10.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Market Performance
10.6.4 BioCryst Pharmaceuticals Business Overview
10.6.5 BioCryst Pharmaceuticals Recent Developments
10.7 KalVista Pharmaceuticals
10.7.1 KalVista Pharmaceuticals Basic Information
10.7.2 KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Overview
10.7.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Market Performance
10.7.4 KalVista Pharmaceuticals Business Overview
10.7.5 KalVista Pharmaceuticals Recent Developments
11 HEREDITARY ANGIOEDEMA TREATMENT MARKET FORECAST BY REGION
11.1 Global Hereditary Angioedema Treatment Market Size Forecast
11.2 Global Hereditary Angioedema Treatment Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Hereditary Angioedema Treatment Market Size Forecast by Country
11.2.3 Asia Pacific Hereditary Angioedema Treatment Market Size Forecast by Region
11.2.4 South America Hereditary Angioedema Treatment Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Hereditary Angioedema Treatment by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Hereditary Angioedema Treatment Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Hereditary Angioedema Treatment by Type (2026-2033)
12.1.2 Global Hereditary Angioedema Treatment Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Hereditary Angioedema Treatment by Type (2026-2033)
12.2 Global Hereditary Angioedema Treatment Market Forecast by Application (2026-2033)
12.2.1 Global Hereditary Angioedema Treatment Sales (K MT) Forecast by Application
12.2.2 Global Hereditary Angioedema Treatment Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Hereditary Angioedema Treatment
1.2 Key Market Segments
1.2.1 Hereditary Angioedema Treatment Segment by Type
1.2.2 Hereditary Angioedema Treatment Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HEREDITARY ANGIOEDEMA TREATMENT MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hereditary Angioedema Treatment Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Hereditary Angioedema Treatment Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HEREDITARY ANGIOEDEMA TREATMENT MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Hereditary Angioedema Treatment Product Life Cycle
3.3 Global Hereditary Angioedema Treatment Sales by Manufacturers (2020-2025)
3.4 Global Hereditary Angioedema Treatment Revenue Market Share by Manufacturers (2020-2025)
3.5 Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Hereditary Angioedema Treatment Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Hereditary Angioedema Treatment Sales Sites, Area Served, Product Type
3.8 Hereditary Angioedema Treatment Market Competitive Situation and Trends
3.8.1 Hereditary Angioedema Treatment Market Concentration Rate
3.8.2 Global 5 and 10 Largest Hereditary Angioedema Treatment Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HEREDITARY ANGIOEDEMA TREATMENT INDUSTRY CHAIN ANALYSIS
4.1 Hereditary Angioedema Treatment Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HEREDITARY ANGIOEDEMA TREATMENT MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 PEST Analysis
5.6.1 Industry Policies Analysis
5.6.2 Economic Environment Analysis
5.6.3 Social Environment Analysis
5.6.4 Technological Environment Analysis
5.7 Global Hereditary Angioedema Treatment Market Porter's Five Forces Analysis
5.7.1 Global Trade Frictions
5.7.2 Global Trade Frictions and Their Impacts to Hereditary Angioedema Treatment Market
5.8 ESG Ratings of Leading Companies
6 HEREDITARY ANGIOEDEMA TREATMENT MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hereditary Angioedema Treatment Sales Market Share by Type (2020-2025)
6.3 Global Hereditary Angioedema Treatment Market Size Market Share by Type (2020-2025)
6.4 Global Hereditary Angioedema Treatment Price by Type (2020-2025)
7 HEREDITARY ANGIOEDEMA TREATMENT MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hereditary Angioedema Treatment Market Sales by Application (2020-2025)
7.3 Global Hereditary Angioedema Treatment Market Size (M USD) by Application (2020-2025)
7.4 Global Hereditary Angioedema Treatment Sales Growth Rate by Application (2020-2025)
8 HEREDITARY ANGIOEDEMA TREATMENT MARKET SALES BY REGION
8.1 Global Hereditary Angioedema Treatment Sales by Region
8.1.1 Global Hereditary Angioedema Treatment Sales by Region
8.1.2 Global Hereditary Angioedema Treatment Sales Market Share by Region
8.2 Global Hereditary Angioedema Treatment Market Size by Region
8.2.1 Global Hereditary Angioedema Treatment Market Size by Region
8.2.2 Global Hereditary Angioedema Treatment Market Size Market Share by Region
8.3 North America
8.3.1 North America Hereditary Angioedema Treatment Sales by Country
8.3.2 North America Hereditary Angioedema Treatment Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Hereditary Angioedema Treatment Sales by Country
8.4.2 Europe Hereditary Angioedema Treatment Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Hereditary Angioedema Treatment Sales by Region
8.5.2 Asia Pacific Hereditary Angioedema Treatment Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Hereditary Angioedema Treatment Sales by Country
8.6.2 South America Hereditary Angioedema Treatment Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Hereditary Angioedema Treatment Sales by Region
8.7.2 Middle East and Africa Hereditary Angioedema Treatment Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HEREDITARY ANGIOEDEMA TREATMENT MARKET PRODUCTION BY REGION
9.1 Global Production of Hereditary Angioedema Treatment by Region(2020-2025)
9.2 Global Hereditary Angioedema Treatment Revenue Market Share by Region (2020-2025)
9.3 Global Hereditary Angioedema Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Hereditary Angioedema Treatment Production
9.4.1 North America Hereditary Angioedema Treatment Production Growth Rate (2020-2025)
9.4.2 North America Hereditary Angioedema Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Hereditary Angioedema Treatment Production
9.5.1 Europe Hereditary Angioedema Treatment Production Growth Rate (2020-2025)
9.5.2 Europe Hereditary Angioedema Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Hereditary Angioedema Treatment Production (2020-2025)
9.6.1 Japan Hereditary Angioedema Treatment Production Growth Rate (2020-2025)
9.6.2 Japan Hereditary Angioedema Treatment Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Hereditary Angioedema Treatment Production (2020-2025)
9.7.1 China Hereditary Angioedema Treatment Production Growth Rate (2020-2025)
9.7.2 China Hereditary Angioedema Treatment Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CSL
10.1.1 CSL Basic Information
10.1.2 CSL Hereditary Angioedema Treatment Product Overview
10.1.3 CSL Hereditary Angioedema Treatment Product Market Performance
10.1.4 CSL Business Overview
10.1.5 CSL SWOT Analysis
10.1.6 CSL Recent Developments
10.2 Pharming Group
10.2.1 Pharming Group Basic Information
10.2.2 Pharming Group Hereditary Angioedema Treatment Product Overview
10.2.3 Pharming Group Hereditary Angioedema Treatment Product Market Performance
10.2.4 Pharming Group Business Overview
10.2.5 Pharming Group SWOT Analysis
10.2.6 Pharming Group Recent Developments
10.3 Shire plc (Takeda Pharmaceutical Company Limited)
10.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Basic Information
10.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Overview
10.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Market Performance
10.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Business Overview
10.3.5 Shire plc (Takeda Pharmaceutical Company Limited) SWOT Analysis
10.3.6 Shire plc (Takeda Pharmaceutical Company Limited) Recent Developments
10.4 Ionis Pharmaceuticals
10.4.1 Ionis Pharmaceuticals Basic Information
10.4.2 Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Overview
10.4.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Market Performance
10.4.4 Ionis Pharmaceuticals Business Overview
10.4.5 Ionis Pharmaceuticals Recent Developments
10.5 Attune Pharmaceuticals
10.5.1 Attune Pharmaceuticals Basic Information
10.5.2 Attune Pharmaceuticals Hereditary Angioedema Treatment Product Overview
10.5.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Product Market Performance
10.5.4 Attune Pharmaceuticals Business Overview
10.5.5 Attune Pharmaceuticals Recent Developments
10.6 BioCryst Pharmaceuticals
10.6.1 BioCryst Pharmaceuticals Basic Information
10.6.2 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Overview
10.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Market Performance
10.6.4 BioCryst Pharmaceuticals Business Overview
10.6.5 BioCryst Pharmaceuticals Recent Developments
10.7 KalVista Pharmaceuticals
10.7.1 KalVista Pharmaceuticals Basic Information
10.7.2 KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Overview
10.7.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Market Performance
10.7.4 KalVista Pharmaceuticals Business Overview
10.7.5 KalVista Pharmaceuticals Recent Developments
11 HEREDITARY ANGIOEDEMA TREATMENT MARKET FORECAST BY REGION
11.1 Global Hereditary Angioedema Treatment Market Size Forecast
11.2 Global Hereditary Angioedema Treatment Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Hereditary Angioedema Treatment Market Size Forecast by Country
11.2.3 Asia Pacific Hereditary Angioedema Treatment Market Size Forecast by Region
11.2.4 South America Hereditary Angioedema Treatment Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Hereditary Angioedema Treatment by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Hereditary Angioedema Treatment Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Hereditary Angioedema Treatment by Type (2026-2033)
12.1.2 Global Hereditary Angioedema Treatment Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Hereditary Angioedema Treatment by Type (2026-2033)
12.2 Global Hereditary Angioedema Treatment Market Forecast by Application (2026-2033)
12.2.1 Global Hereditary Angioedema Treatment Sales (K MT) Forecast by Application
12.2.2 Global Hereditary Angioedema Treatment Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hereditary Angioedema Treatment Market Size Comparison by Region (M USD)
Table 5. Global Hereditary Angioedema Treatment Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Hereditary Angioedema Treatment Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Hereditary Angioedema Treatment Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Hereditary Angioedema Treatment Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Treatment as of 2024)
Table 10. Global Market Hereditary Angioedema Treatment Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Hereditary Angioedema Treatment Sales Sites and Area Served
Table 12. Manufacturers Hereditary Angioedema Treatment Product Type
Table 13. Global Hereditary Angioedema Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Hereditary Angioedema Treatment Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Hereditary Angioedema Treatment Sales by Type (K MT)
Table 25. Global Hereditary Angioedema Treatment Market Size by Type (M USD)
Table 26. Global Hereditary Angioedema Treatment Sales (K MT) by Type (2020-2025)
Table 27. Global Hereditary Angioedema Treatment Sales Market Share by Type (2020-2025)
Table 28. Global Hereditary Angioedema Treatment Market Size (M USD) by Type (2020-2025)
Table 29. Global Hereditary Angioedema Treatment Market Size Share by Type (2020-2025)
Table 30. Global Hereditary Angioedema Treatment Price (USD/MT) by Type (2020-2025)
Table 31. Global Hereditary Angioedema Treatment Sales (K MT) by Application
Table 32. Global Hereditary Angioedema Treatment Market Size by Application
Table 33. Global Hereditary Angioedema Treatment Sales by Application (2020-2025) & (K MT)
Table 34. Global Hereditary Angioedema Treatment Sales Market Share by Application (2020-2025)
Table 35. Global Hereditary Angioedema Treatment Market Size by Application (2020-2025) & (M USD)
Table 36. Global Hereditary Angioedema Treatment Market Share by Application (2020-2025)
Table 37. Global Hereditary Angioedema Treatment Sales Growth Rate by Application (2020-2025)
Table 38. Global Hereditary Angioedema Treatment Sales by Region (2020-2025) & (K MT)
Table 39. Global Hereditary Angioedema Treatment Sales Market Share by Region (2020-2025)
Table 40. Global Hereditary Angioedema Treatment Market Size by Region (2020-2025) & (M USD)
Table 41. Global Hereditary Angioedema Treatment Market Size Market Share by Region (2020-2025)
Table 42. North America Hereditary Angioedema Treatment Sales by Country (2020-2025) & (K MT)
Table 43. North America Hereditary Angioedema Treatment Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Hereditary Angioedema Treatment Sales by Country (2020-2025) & (K MT)
Table 45. Europe Hereditary Angioedema Treatment Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Hereditary Angioedema Treatment Sales by Region (2020-2025) & (K MT)
Table 47. Asia Pacific Hereditary Angioedema Treatment Market Size by Region (2020-2025) & (M USD)
Table 48. South America Hereditary Angioedema Treatment Sales by Country (2020-2025) & (K MT)
Table 49. South America Hereditary Angioedema Treatment Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Hereditary Angioedema Treatment Sales by Region (2020-2025) & (K MT)
Table 51. Middle East and Africa Hereditary Angioedema Treatment Market Size by Region (2020-2025) & (M USD)
Table 52. Global Hereditary Angioedema Treatment Production (K MT) by Region(2020-2025)
Table 53. Global Hereditary Angioedema Treatment Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Hereditary Angioedema Treatment Revenue Market Share by Region (2020-2025)
Table 55. Global Hereditary Angioedema Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. North America Hereditary Angioedema Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Europe Hereditary Angioedema Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Japan Hereditary Angioedema Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. China Hereditary Angioedema Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. CSL Basic Information
Table 61. CSL Hereditary Angioedema Treatment Product Overview
Table 62. CSL Hereditary Angioedema Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 63. CSL Business Overview
Table 64. CSL SWOT Analysis
Table 65. CSL Recent Developments
Table 66. Pharming Group Basic Information
Table 67. Pharming Group Hereditary Angioedema Treatment Product Overview
Table 68. Pharming Group Hereditary Angioedema Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 69. Pharming Group Business Overview
Table 70. Pharming Group SWOT Analysis
Table 71. Pharming Group Recent Developments
Table 72. Shire plc (Takeda Pharmaceutical Company Limited) Basic Information
Table 73. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Overview
Table 74. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Shire plc (Takeda Pharmaceutical Company Limited) Business Overview
Table 76. Shire plc (Takeda Pharmaceutical Company Limited) SWOT Analysis
Table 77. Shire plc (Takeda Pharmaceutical Company Limited) Recent Developments
Table 78. Ionis Pharmaceuticals Basic Information
Table 79. Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Overview
Table 80. Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Ionis Pharmaceuticals Business Overview
Table 82. Ionis Pharmaceuticals Recent Developments
Table 83. Attune Pharmaceuticals Basic Information
Table 84. Attune Pharmaceuticals Hereditary Angioedema Treatment Product Overview
Table 85. Attune Pharmaceuticals Hereditary Angioedema Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Attune Pharmaceuticals Business Overview
Table 87. Attune Pharmaceuticals Recent Developments
Table 88. BioCryst Pharmaceuticals Basic Information
Table 89. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Overview
Table 90. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. BioCryst Pharmaceuticals Business Overview
Table 92. BioCryst Pharmaceuticals Recent Developments
Table 93. KalVista Pharmaceuticals Basic Information
Table 94. KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Overview
Table 95. KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. KalVista Pharmaceuticals Business Overview
Table 97. KalVista Pharmaceuticals Recent Developments
Table 98. Global Hereditary Angioedema Treatment Sales Forecast by Region (2026-2033) & (K MT)
Table 99. Global Hereditary Angioedema Treatment Market Size Forecast by Region (2026-2033) & (M USD)
Table 100. North America Hereditary Angioedema Treatment Sales Forecast by Country (2026-2033) & (K MT)
Table 101. North America Hereditary Angioedema Treatment Market Size Forecast by Country (2026-2033) & (M USD)
Table 102. Europe Hereditary Angioedema Treatment Sales Forecast by Country (2026-2033) & (K MT)
Table 103. Europe Hereditary Angioedema Treatment Market Size Forecast by Country (2026-2033) & (M USD)
Table 104. Asia Pacific Hereditary Angioedema Treatment Sales Forecast by Region (2026-2033) & (K MT)
Table 105. Asia Pacific Hereditary Angioedema Treatment Market Size Forecast by Region (2026-2033) & (M USD)
Table 106. South America Hereditary Angioedema Treatment Sales Forecast by Country (2026-2033) & (K MT)
Table 107. South America Hereditary Angioedema Treatment Market Size Forecast by Country (2026-2033) & (M USD)
Table 108. Middle East and Africa Hereditary Angioedema Treatment Sales Forecast by Country (2026-2033) & (Units)
Table 109. Middle East and Africa Hereditary Angioedema Treatment Market Size Forecast by Country (2026-2033) & (M USD)
Table 110. Global Hereditary Angioedema Treatment Sales Forecast by Type (2026-2033) & (K MT)
Table 111. Global Hereditary Angioedema Treatment Market Size Forecast by Type (2026-2033) & (M USD)
Table 112. Global Hereditary Angioedema Treatment Price Forecast by Type (2026-2033) & (USD/MT)
Table 113. Global Hereditary Angioedema Treatment Sales (K MT) Forecast by Application (2026-2033)
Table 114. Global Hereditary Angioedema Treatment Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hereditary Angioedema Treatment Market Size Comparison by Region (M USD)
Table 5. Global Hereditary Angioedema Treatment Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Hereditary Angioedema Treatment Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Hereditary Angioedema Treatment Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Hereditary Angioedema Treatment Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Treatment as of 2024)
Table 10. Global Market Hereditary Angioedema Treatment Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Hereditary Angioedema Treatment Sales Sites and Area Served
Table 12. Manufacturers Hereditary Angioedema Treatment Product Type
Table 13. Global Hereditary Angioedema Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Hereditary Angioedema Treatment Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Hereditary Angioedema Treatment Sales by Type (K MT)
Table 25. Global Hereditary Angioedema Treatment Market Size by Type (M USD)
Table 26. Global Hereditary Angioedema Treatment Sales (K MT) by Type (2020-2025)
Table 27. Global Hereditary Angioedema Treatment Sales Market Share by Type (2020-2025)
Table 28. Global Hereditary Angioedema Treatment Market Size (M USD) by Type (2020-2025)
Table 29. Global Hereditary Angioedema Treatment Market Size Share by Type (2020-2025)
Table 30. Global Hereditary Angioedema Treatment Price (USD/MT) by Type (2020-2025)
Table 31. Global Hereditary Angioedema Treatment Sales (K MT) by Application
Table 32. Global Hereditary Angioedema Treatment Market Size by Application
Table 33. Global Hereditary Angioedema Treatment Sales by Application (2020-2025) & (K MT)
Table 34. Global Hereditary Angioedema Treatment Sales Market Share by Application (2020-2025)
Table 35. Global Hereditary Angioedema Treatment Market Size by Application (2020-2025) & (M USD)
Table 36. Global Hereditary Angioedema Treatment Market Share by Application (2020-2025)
Table 37. Global Hereditary Angioedema Treatment Sales Growth Rate by Application (2020-2025)
Table 38. Global Hereditary Angioedema Treatment Sales by Region (2020-2025) & (K MT)
Table 39. Global Hereditary Angioedema Treatment Sales Market Share by Region (2020-2025)
Table 40. Global Hereditary Angioedema Treatment Market Size by Region (2020-2025) & (M USD)
Table 41. Global Hereditary Angioedema Treatment Market Size Market Share by Region (2020-2025)
Table 42. North America Hereditary Angioedema Treatment Sales by Country (2020-2025) & (K MT)
Table 43. North America Hereditary Angioedema Treatment Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Hereditary Angioedema Treatment Sales by Country (2020-2025) & (K MT)
Table 45. Europe Hereditary Angioedema Treatment Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Hereditary Angioedema Treatment Sales by Region (2020-2025) & (K MT)
Table 47. Asia Pacific Hereditary Angioedema Treatment Market Size by Region (2020-2025) & (M USD)
Table 48. South America Hereditary Angioedema Treatment Sales by Country (2020-2025) & (K MT)
Table 49. South America Hereditary Angioedema Treatment Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Hereditary Angioedema Treatment Sales by Region (2020-2025) & (K MT)
Table 51. Middle East and Africa Hereditary Angioedema Treatment Market Size by Region (2020-2025) & (M USD)
Table 52. Global Hereditary Angioedema Treatment Production (K MT) by Region(2020-2025)
Table 53. Global Hereditary Angioedema Treatment Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Hereditary Angioedema Treatment Revenue Market Share by Region (2020-2025)
Table 55. Global Hereditary Angioedema Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. North America Hereditary Angioedema Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Europe Hereditary Angioedema Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Japan Hereditary Angioedema Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. China Hereditary Angioedema Treatment Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. CSL Basic Information
Table 61. CSL Hereditary Angioedema Treatment Product Overview
Table 62. CSL Hereditary Angioedema Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 63. CSL Business Overview
Table 64. CSL SWOT Analysis
Table 65. CSL Recent Developments
Table 66. Pharming Group Basic Information
Table 67. Pharming Group Hereditary Angioedema Treatment Product Overview
Table 68. Pharming Group Hereditary Angioedema Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 69. Pharming Group Business Overview
Table 70. Pharming Group SWOT Analysis
Table 71. Pharming Group Recent Developments
Table 72. Shire plc (Takeda Pharmaceutical Company Limited) Basic Information
Table 73. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product Overview
Table 74. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Shire plc (Takeda Pharmaceutical Company Limited) Business Overview
Table 76. Shire plc (Takeda Pharmaceutical Company Limited) SWOT Analysis
Table 77. Shire plc (Takeda Pharmaceutical Company Limited) Recent Developments
Table 78. Ionis Pharmaceuticals Basic Information
Table 79. Ionis Pharmaceuticals Hereditary Angioedema Treatment Product Overview
Table 80. Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Ionis Pharmaceuticals Business Overview
Table 82. Ionis Pharmaceuticals Recent Developments
Table 83. Attune Pharmaceuticals Basic Information
Table 84. Attune Pharmaceuticals Hereditary Angioedema Treatment Product Overview
Table 85. Attune Pharmaceuticals Hereditary Angioedema Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Attune Pharmaceuticals Business Overview
Table 87. Attune Pharmaceuticals Recent Developments
Table 88. BioCryst Pharmaceuticals Basic Information
Table 89. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product Overview
Table 90. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. BioCryst Pharmaceuticals Business Overview
Table 92. BioCryst Pharmaceuticals Recent Developments
Table 93. KalVista Pharmaceuticals Basic Information
Table 94. KalVista Pharmaceuticals Hereditary Angioedema Treatment Product Overview
Table 95. KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. KalVista Pharmaceuticals Business Overview
Table 97. KalVista Pharmaceuticals Recent Developments
Table 98. Global Hereditary Angioedema Treatment Sales Forecast by Region (2026-2033) & (K MT)
Table 99. Global Hereditary Angioedema Treatment Market Size Forecast by Region (2026-2033) & (M USD)
Table 100. North America Hereditary Angioedema Treatment Sales Forecast by Country (2026-2033) & (K MT)
Table 101. North America Hereditary Angioedema Treatment Market Size Forecast by Country (2026-2033) & (M USD)
Table 102. Europe Hereditary Angioedema Treatment Sales Forecast by Country (2026-2033) & (K MT)
Table 103. Europe Hereditary Angioedema Treatment Market Size Forecast by Country (2026-2033) & (M USD)
Table 104. Asia Pacific Hereditary Angioedema Treatment Sales Forecast by Region (2026-2033) & (K MT)
Table 105. Asia Pacific Hereditary Angioedema Treatment Market Size Forecast by Region (2026-2033) & (M USD)
Table 106. South America Hereditary Angioedema Treatment Sales Forecast by Country (2026-2033) & (K MT)
Table 107. South America Hereditary Angioedema Treatment Market Size Forecast by Country (2026-2033) & (M USD)
Table 108. Middle East and Africa Hereditary Angioedema Treatment Sales Forecast by Country (2026-2033) & (Units)
Table 109. Middle East and Africa Hereditary Angioedema Treatment Market Size Forecast by Country (2026-2033) & (M USD)
Table 110. Global Hereditary Angioedema Treatment Sales Forecast by Type (2026-2033) & (K MT)
Table 111. Global Hereditary Angioedema Treatment Market Size Forecast by Type (2026-2033) & (M USD)
Table 112. Global Hereditary Angioedema Treatment Price Forecast by Type (2026-2033) & (USD/MT)
Table 113. Global Hereditary Angioedema Treatment Sales (K MT) Forecast by Application (2026-2033)
Table 114. Global Hereditary Angioedema Treatment Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Hereditary Angioedema Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hereditary Angioedema Treatment Market Size (M USD), 2024-2033
Figure 5. Global Hereditary Angioedema Treatment Market Size (M USD) (2020-2033)
Figure 6. Global Hereditary Angioedema Treatment Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hereditary Angioedema Treatment Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Hereditary Angioedema Treatment Product Life Cycle
Figure 13. Hereditary Angioedema Treatment Sales Share by Manufacturers in 2024
Figure 14. Global Hereditary Angioedema Treatment Revenue Share by Manufacturers in 2024
Figure 15. Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Hereditary Angioedema Treatment Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Hereditary Angioedema Treatment Revenue in 2024
Figure 18. Industry Chain Map of Hereditary Angioedema Treatment
Figure 19. Global Hereditary Angioedema Treatment Market PESTE Analysis
Figure 20. Global Hereditary Angioedema Treatment Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Hereditary Angioedema Treatment Market Share by Type
Figure 27. Sales Market Share of Hereditary Angioedema Treatment by Type (2020-2025)
Figure 28. Sales Market Share of Hereditary Angioedema Treatment by Type in 2024
Figure 29. Market Size Share of Hereditary Angioedema Treatment by Type (2020-2025)
Figure 30. Market Size Share of Hereditary Angioedema Treatment by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Hereditary Angioedema Treatment Market Share by Application
Figure 33. Global Hereditary Angioedema Treatment Sales Market Share by Application (2020-2025)
Figure 34. Global Hereditary Angioedema Treatment Sales Market Share by Application in 2024
Figure 35. Global Hereditary Angioedema Treatment Market Share by Application (2020-2025)
Figure 36. Global Hereditary Angioedema Treatment Market Share by Application in 2024
Figure 37. Global Hereditary Angioedema Treatment Sales Growth Rate by Application (2020-2025)
Figure 38. Global Hereditary Angioedema Treatment Sales Market Share by Region (2020-2025)
Figure 39. Global Hereditary Angioedema Treatment Market Size Market Share by Region (2020-2025)
Figure 40. North America Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Hereditary Angioedema Treatment Sales Market Share by Country in 2024
Figure 43. North America Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Hereditary Angioedema Treatment Market Size Market Share by Country in 2024
Figure 45. U.S. Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Hereditary Angioedema Treatment Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Hereditary Angioedema Treatment Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Hereditary Angioedema Treatment Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Hereditary Angioedema Treatment Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Hereditary Angioedema Treatment Sales Market Share by Country in 2024
Figure 53. Europe Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Hereditary Angioedema Treatment Market Size Market Share by Country in 2024
Figure 55. Germany Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Hereditary Angioedema Treatment Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Hereditary Angioedema Treatment Sales Market Share by Region in 2024
Figure 67. Asia Pacific Hereditary Angioedema Treatment Market Size Market Share by Region in 2024
Figure 68. China Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Hereditary Angioedema Treatment Sales and Growth Rate (K MT)
Figure 79. South America Hereditary Angioedema Treatment Sales Market Share by Country in 2024
Figure 80. South America Hereditary Angioedema Treatment Market Size and Growth Rate (M USD)
Figure 81. South America Hereditary Angioedema Treatment Market Size Market Share by Country in 2024
Figure 82. Brazil Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Hereditary Angioedema Treatment Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Hereditary Angioedema Treatment Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Hereditary Angioedema Treatment Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Hereditary Angioedema Treatment Production Market Share by Region (2020-2025)
Figure 103. North America Hereditary Angioedema Treatment Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Hereditary Angioedema Treatment Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Hereditary Angioedema Treatment Production (K MT) Growth Rate (2020-2025)
Figure 106. China Hereditary Angioedema Treatment Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Hereditary Angioedema Treatment Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Hereditary Angioedema Treatment Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Hereditary Angioedema Treatment Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Hereditary Angioedema Treatment Market Share Forecast by Type (2026-2033)
Figure 111. Global Hereditary Angioedema Treatment Sales Forecast by Application (2026-2033)
Figure 112. Global Hereditary Angioedema Treatment Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Hereditary Angioedema Treatment
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hereditary Angioedema Treatment Market Size (M USD), 2024-2033
Figure 5. Global Hereditary Angioedema Treatment Market Size (M USD) (2020-2033)
Figure 6. Global Hereditary Angioedema Treatment Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hereditary Angioedema Treatment Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Hereditary Angioedema Treatment Product Life Cycle
Figure 13. Hereditary Angioedema Treatment Sales Share by Manufacturers in 2024
Figure 14. Global Hereditary Angioedema Treatment Revenue Share by Manufacturers in 2024
Figure 15. Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Hereditary Angioedema Treatment Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Hereditary Angioedema Treatment Revenue in 2024
Figure 18. Industry Chain Map of Hereditary Angioedema Treatment
Figure 19. Global Hereditary Angioedema Treatment Market PESTE Analysis
Figure 20. Global Hereditary Angioedema Treatment Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Hereditary Angioedema Treatment Market Share by Type
Figure 27. Sales Market Share of Hereditary Angioedema Treatment by Type (2020-2025)
Figure 28. Sales Market Share of Hereditary Angioedema Treatment by Type in 2024
Figure 29. Market Size Share of Hereditary Angioedema Treatment by Type (2020-2025)
Figure 30. Market Size Share of Hereditary Angioedema Treatment by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Hereditary Angioedema Treatment Market Share by Application
Figure 33. Global Hereditary Angioedema Treatment Sales Market Share by Application (2020-2025)
Figure 34. Global Hereditary Angioedema Treatment Sales Market Share by Application in 2024
Figure 35. Global Hereditary Angioedema Treatment Market Share by Application (2020-2025)
Figure 36. Global Hereditary Angioedema Treatment Market Share by Application in 2024
Figure 37. Global Hereditary Angioedema Treatment Sales Growth Rate by Application (2020-2025)
Figure 38. Global Hereditary Angioedema Treatment Sales Market Share by Region (2020-2025)
Figure 39. Global Hereditary Angioedema Treatment Market Size Market Share by Region (2020-2025)
Figure 40. North America Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Hereditary Angioedema Treatment Sales Market Share by Country in 2024
Figure 43. North America Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Hereditary Angioedema Treatment Market Size Market Share by Country in 2024
Figure 45. U.S. Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Hereditary Angioedema Treatment Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Hereditary Angioedema Treatment Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Hereditary Angioedema Treatment Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Hereditary Angioedema Treatment Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Hereditary Angioedema Treatment Sales Market Share by Country in 2024
Figure 53. Europe Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Hereditary Angioedema Treatment Market Size Market Share by Country in 2024
Figure 55. Germany Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Hereditary Angioedema Treatment Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Hereditary Angioedema Treatment Sales Market Share by Region in 2024
Figure 67. Asia Pacific Hereditary Angioedema Treatment Market Size Market Share by Region in 2024
Figure 68. China Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Hereditary Angioedema Treatment Sales and Growth Rate (K MT)
Figure 79. South America Hereditary Angioedema Treatment Sales Market Share by Country in 2024
Figure 80. South America Hereditary Angioedema Treatment Market Size and Growth Rate (M USD)
Figure 81. South America Hereditary Angioedema Treatment Market Size Market Share by Country in 2024
Figure 82. Brazil Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Hereditary Angioedema Treatment Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Hereditary Angioedema Treatment Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Hereditary Angioedema Treatment Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Hereditary Angioedema Treatment Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Hereditary Angioedema Treatment Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Hereditary Angioedema Treatment Production Market Share by Region (2020-2025)
Figure 103. North America Hereditary Angioedema Treatment Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Hereditary Angioedema Treatment Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Hereditary Angioedema Treatment Production (K MT) Growth Rate (2020-2025)
Figure 106. China Hereditary Angioedema Treatment Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Hereditary Angioedema Treatment Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Hereditary Angioedema Treatment Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Hereditary Angioedema Treatment Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Hereditary Angioedema Treatment Market Share Forecast by Type (2026-2033)
Figure 111. Global Hereditary Angioedema Treatment Sales Forecast by Application (2026-2033)
Figure 112. Global Hereditary Angioedema Treatment Market Share Forecast by Application (2026-2033)
